TP53 and breast cancer: DIM treatment resulted in an up-regulation of miR-21 in MCF-7 cells but not in the TNBC MDA-MB-468 p53 mutants, indicating that ER or p53 status is crucial for the DIM-related effect on miR-21 in BC (141, 142).